Effect of Mean Arterial Pressure (MAP)-Based Preeclampsia Screening Training on Midwives’ Knowledge
Abstract
Introduction: Preeclampsia remains a major cause of maternal morbidity and mortality worldwide, making early risk identification an important component of antenatal care. Mean Arterial Pressure (MAP) has been recommended as a simple and cost-effective screening method for predicting the risk of preeclampsia. However, its application in primary healthcare settings remains limited. This study aimed to evaluate the effect of MAP-based preeclampsia screening training on midwives’ knowledge of early preeclampsia detection.
Methods: A one-group pretest–posttest study was conducted among midwives participating in a MAP-based preeclampsia screening training program. Forty-two midwives attended the training, and 37 who completed both assessments were included in the analysis. The training covered the concept of MAP, accurate blood pressure measurement procedures, MAP calculation, and interpretation of MAP values for identifying women at risk of preeclampsia. Knowledge was assessed using a structured 20-item questionnaire administered before and after the training. Data normality was tested using the Kolmogorov–Smirnov test, and differences between pretest and posttest scores were analyzed using the Wilcoxon Signed Rank Test.
Results: Knowledge scores improved following the training, with a mean increase of 3.35 points. Statistical analysis showed a significant difference between pretest and posttest scores (p = 0.018), indicating that the training effectively enhanced participants’ understanding of MAP-based preeclampsia screening. The findings suggest that a short structured educational intervention can improve knowledge related to early preeclampsia detection.
Conclusion: MAP-based preeclampsia screening training significantly improved midwives’ knowledge regarding early detection of preeclampsia. Incorporating similar training into continuing professional development programs may strengthen early risk identification in maternal healthcare. Further studies with larger samples, control groups, and longer follow-up periods are needed to assess knowledge retention and clinical implementation.
References
World Health Organization, “WHO recommendations on drug treatment for non-severe hypertension in pregnancy,” Geneva, 2020. https://www.who.int/publications/i/item/9789240008793
K. K. R. Indonesia, “Profil Kesehatan Indonesia 2024,” Jakarta: Kementerian Kesehatan RI, 2025. https://kemkes.go.id/id/profil-kesehatan-indonesia-2024.
M. Mustary, A. Syam, S. Riskiyani, K. A. Erika, A. I. Moedjiono, and M. Lubis, “Review article Preeclampsia: Etiology, Pathophysiology, Risk Factors, Impact and Prevention: A Narrative Review,” vol. 53, no. 11, pp. 2392–2403, 2024.
D. D. Sharma, N. R. Chandresh, A. Javed, P. Girgis, and M. Zeeshan, “The Management of Preeclampsia: A Comprehensive Review of Current Practices and Future Directions,” vol. 16, no. 1, pp. 1–10, 2024, doi: https://doi.org/10.7759/cureus.51512.
L. C. Poon, A. Shennan, J. A. Hyett, A. Kapur, E. Hadar, and H. Divakar, “The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention,” Int. J. Gynecol. Obstet., vol. 145, no. S1, pp. 1–33, 2019, doi: https://doi.org/10.1002/ijgo.12802.
G. Alipova, N. Ablakimova, K. Tussupkaliyeva, S. Bermagambetova, and A. Tussupkaliyev, “Prevention of Pre-Eclampsia: Modern Strategies and the Role of Early Screening,” pp. 1–21, 2025.
S. Ronzoni, S. Rashid, A. Santoro, E. M. Dan, J. Barrett, and N. Okun, “Preterm preeclampsia screening and prevention: A comprehensive approach to implementation in a real-world setting,” BMC Pregnancy Childbirth, vol. 6, 2025, doi: https://doi.org/10.1186/s12884-025-07154-6.
E. Susilawati, “Antenatal screening of pregnancy risk using KSPR in high-risk pregnant women,” J. Prot. Kesehat., vol. 12, pp. 177–183, 2023.
J. Mao, H. Sun, Q. Shen, C. Zou, Y. Yang, and Q. Du, “Impact of pre-pregnancy body mass index on preeclampsia,” Front. Med., vol. 12, p. 1529966, 2025, doi: https://doi.org/10.3389/fmed.2025.1529966.
J. Zhu, J. Zhang, N. S. Razali, B. Chern, and K. H. Tan, “Mean arterial pressure for predicting preeclampsia in Asian women: A longitudinal cohort study,” BMJ Open, vol. 11, p. e046161, 2021, doi: https://doi.org/10.1136/bmjopen-2020-046161.
H. S, N. A. Mappaware, and Aminuddin, “Change in mean arterial pressure (MAP), roll over test (ROT), and soluble fms-like tyrosine kinase-1 (sFlt-1) as predictors of preeclampsia in pregnant women receiving ajwa dates,” Enferm. Clin., vol. 30, no. 4, pp. 325–283, 2020, doi: https://doi.org/10.1016/j.enfcli.2020.06.073.
M. Côté, B. A, C. Gasse, S. Demers, and E. Bujold, “First trimester mean arterial pressure measured manually versus using an automated device and the prediction of preeclampsia: A case-cohort study,” J. Obstet. Gynaecol., vol. 42, no. 3, pp. 277–283, 2020, doi: https://doi.org/10.1016/j.jogc.2019.06.017.
A. Nanda et al., “Comparison of first trimester preeclampsia combined screening performances with various approaches in the Indonesian population,” J. Perinatol., no. February, 2025, doi: https://doi.org/10.1038/s41372-025-02316-y.
A. D. Destiyani and U. M. Diniyah, “Skrining Preeklampsia pada Ibu Hamil Menggunakan Mean Arterial Pressure,” vol. 16, no. 2, pp. 176–183, 2023, doi: https://doi.org/10.23917/jk.v16i2.2004.
A. Hurrell, L. Webster, L. C. Chappell, and A. Shennan, “The assessment of blood pressure in pregnant women: Pitfalls and novel approaches,” Am. J. Obstet. Gynecol., vol. 226, no. 2S, pp. S804–S818, 2022, doi: https://doi.org/10.1016/j.ajog.2020.10.026.
D. C. Ashworth, S. P. Maule, F. Stewart, H. L. Nathan, A. H. Shennan, and L. C. Chappell, “Setting and techniques for monitoring blood pressure during pregnancy,” Cochrane Database Syst. Rev., vol. 5, no. CD012739, 2020, doi: https://doi.org/10.1002/14651858.CD012739.pub2.
H. M. Denny, A. D. Laksono, R. Matahari, and B. Kurniawan, “The Determinants of Four or More Antenatal Care Visits Among Working Women in Indonesia,” no. 1269, 2022, doi: https://doi.org/10.1177/10105395211051237.
T. Huang et al., “Modified multiple marker aneuploidy screening as a primary screening test for preeclampsia,” BMC Pregnancy Childbirth, pp. 1–14, 2022, doi: https://doi.org/10.1186/s12884-022-04514-4.
S. Izumi, N. Iwama, and H. Metoki, “Prediction of preterm preeclampsia risk in Asians using a simple two-item assessment in early pregnancy,” pp. 1231–1234, 2024, doi: https://doi.org/10.1038/s41440-024-01590-1.
I. Garti, M. Gray, J. Y. Tan, and A. Bromley, “Midwives’ knowledge of pre-eclampsia management: A scoping review,” Women Birth, vol. 34, no. 1, pp. 87–104, 2021, doi: https://doi.org/10.1016/j.wombi.2020.08.010.
I. Garti, M. Gray, A. Bromley, and J. Y. Tan, “Pre-eclampsia training needs of midwives in a Ghanaian tertiary hospital: A cross-sectional study,” Nurse Educ. Pract., vol. 75, no. 103872, 2024, doi: https://doi.org/10.1016/j.nepr.2024.103872.
S. I. Iskandar, S. Aryanto, S. Prawitasari, and B. S. Wiratama, “Strengthening the first antenatal visit to improve maternal health: Results from a cross-sectional study in Bantul, Indonesia,” BMC Pregnancy Childbirth, vol. 25, no. 412, 2025, doi: https://doi.org/10.1186/s12884-025-08038-5.
M. Silaen, S. Rahayu, I. Aryanti, A. Prasetyo, and S. Wahyuni, “Health and socio-economic factors as determinants of antenatal care service access in Indonesia,” Clin. Epidemiol. Glob. Health, vol. 33, no. August 2024, p. 102010, 2025, doi: https://doi.org/10.1016/j.cegh.2025.102010.
K. Chang, K. Seow, and K. Chen, “Preeclampsia: Recent Advances in Predicting, Preventing, and Managing the Maternal and Fetal Life-Threatening Condition,” 2023.
J. T.-Torres et al., “A first-trimester mechanistic framework integrating three physiopathologic biomarker domains for pre-eclampsia classification,” no. December 2025, pp. 1–10, 2026, doi: https://doi.org/10.1002/ijgo.70804.
Copyright (c) 2026 Media Publikasi Promosi Kesehatan Indonesia (MPPKI)

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with Media Publikasi Promosi Kesehatan Indonesia retain the copyright of their work. The journal applies a Creative Commons Attribution-ShareAlike 4.0 International License (CC BY-SA 4.0), which grants the following rights:
-
Copyright Retention: Authors retain the copyright of their work, maintaining full control over their intellectual property without restrictions.
-
Right of First Publication: Authors grant the journal the right of first publication of their work. This ensures that the work is initially published and credited in Media Publikasi Promosi Kesehatan Indonesia.
-
License to Share and Reuse: The work is licensed under CC BY-SA 4.0, allowing others to copy, distribute, remix, and build upon the work for any purpose, even commercially, as long as proper credit is given to the authors, and any new creations are licensed under the same terms.